CVS PHARMACY INC
Pharmacy · GRANBY, MA
Organization Active NPI 1932473246
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 989 | 3,300 | $264,995 | $259,166 | $259,166 |
| 2023 | 1,062 | 5,169 | $218,810 | $211,381 | $211,381 |
| 2022 | 1,342 | 6,403 | $161,168 | $147,510 | $147,510 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| 90480 | Admn sarscov2 vacc 1 dose | 806 | $43 | $43 |
| G0008 | Administration of influenza virus vaccine | 790 | $30 | $30 |
| 91320 | Sarscv2 vac 30mcg trs-suc im | 642 | $153 | $153 |
| 90662 | Influenza vaccine split virus, preservative free | 396 | $82 | $82 |
| 90653 | Influenza vaccine, inactivated | 346 | $82 | $82 |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | 151 | $143 | $143 |
| G0009 | Administration of pneumococcal vaccine | 54 | $33 | $33 |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | 51 | $292 | $292 |
| 90661 | Influenza vaccine, trivalent derived from cell cultures | 26 | $36 | $36 |
| 90656 | Influenza vaccine, trivalent, split virus, preservative-free, 0.5 ml dosage | 19 | $22 | $22 |
| 91304 | Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5ml dosage, for intramuscular use | 13 | $157 | $157 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Pharmacy | 333600000X | ✓ | — | — |
| Durable Medical Equipment & Medical Supplies | 332B00000X | — | — | |
| Community/Retail Pharmacy | 3336C0003X | — | — |
Other Pharmacy providers in Massachusetts
- NPI 1497463095
- NPI 1033722830
- NPI 1821043027
- NPI 1598618233
- NPI 1386350221
- NPI 1912346974
- NPI 1457170524
- NPI 1063648087
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.